Obermatt
See Similar Stocks →

Nautilus Biotechnology

NAQ:NAUT · US63909J1088
Life Sciences Tools & ServicesSmall

360° View

26
Price/Sales1
Price/Earnings—
Price/Book34
Dividend Yield1
Revenue Growth—
Profit Growth31
Capital Growth46
TSR 52w99
Leverage70
Liquidity75
Refinancing13
Combined19
Analyst Opinions100
Pro Holdings11
Opinion Changes50
Market Pulse41

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees131
Websitenautilus.bio
ISINUS63909J1088
Last UpdateApr 2, 2026
Index & Theme
Machine LearningHealth DiagnosticsSoftware DevelopmentArtificial IntelligencePredictive AnalyticsBiotechnologyHealth CareLife SciencePharmaceutical

Description

Nautilus Biotechnology, Inc. (Nautilus), a development stage life sciences company, creates a platform technology for quantifying and unlocking the complexity of the proteome. By leveraging the company’s novel platform design, coupled with advanced…

Analysis

Nautilus Biotechnology's 360° View rank of 26 places it below its peer average — better than 26% of its true peers.

It's growing solidly (75) and expensive versus peers (10). On safety it is carrying more balance-sheet risk (38), and the market shows favorable sentiment (57). Taken together, its Combined rank of 19 reads as among the weakest overall.

360° rank · history

1007550250
26
2026

All-time high

35

Mar 2026

All-time low

26

Jun 2026

Average rank

31

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
1
—
—
—
Price/Earnings
—
—
—
—
Price/Book
34
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
10
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Nautilus Biotechnology with its peers
10x Genomics
NSQ:TXG
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Adaptive Biotechnologies
NSQ:ADPT
20
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Bio-Techne
NSQ:TECH
74
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Seer
NSQ:SEER
43
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Standard BioTools
NSQ:LAB
60
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Bio-Rad Laboratories
NYQ:BIO
48
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →